Case Report: Synergistic central nervous system depression of baclofen and pregabalin: clinical pharmacist-driven
Yitong Xie1,2, Danwei Wu2, Peihao Jin3
1School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Background:
Baclofen, a γ-aminobutyric acid (GABA) derivative, and Pregabalin, a GABA analogue, are widely prescribed for muscle spasm and neuropathic pain. This first-reported case demonstrates synergistic central nervous system (CNS) depression of Baclofen (30 mg/day) and Pregabalin (300 mg/day) in a patient with mild renal impairment [estimated glomerular filtration rate, (eGFR) = 77.26 mL/min].
Case Presentation:
A 68-year-old female with renal impairment developed progressive CNS depression (somnolence, coma) following combined Baclofen (30 mg/day) and Pregabalin (300 mg/day) therapy after spinal fusion surgery. CNS depression was completely resolved 48 h after drug discontinuation.
Conclusion:
Clinicians should exercise heightened caution when combining Baclofen and Pregabalin in renal impairment. Dose adjustments based on creatinine clearance (CLcr) are strongly recommended. Particular attention should be given to initiating therapy with reduced starting doses in patients at elevated risk of CNS depression.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Anxiolytic Drugs: Benzodiazepines and Buspirone
Bipolar Disorder
Drug Therapy
Antianxiety Medications


